A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
Trending
- Livestock: FG to overhaul regulations for milk collection
- Cross River gov extends maternity leave
- Foundation advocates treatment, skills acquisition for VVF survivors
- Tinubu presents N47trn 2025 budget to NASS
- Mozambique’s cyclone Chido death toll hits 45
- NAFDAC alerts Nigerians to sale of counterfeit Paudex tablets
- FUTA VC advises fresh students on internet use, anti-social behaviour
- Celebrating 25 years of impact: Busari launches global storytelling academy
